Robust detection for confident diagnostics
SARS-CoV-2 continues to mutate, giving rise to variants potentially impacting diagnostic testing and reporting. Reliable and accurate diagnostics are required by laboratories to save time, resources, and to have confidence in the data reported.
SpeeDx routinely monitors the ability of our PlexPCR® SARS-CoV-2 assay to detect emerging COVID variants. We have determined that our sequences match those seen in the recently reported Omicron variant, as well all other previously identified variants, to provide assurance that your laboratory can confidently report test results. Learn more.
Secure supply chain with PlexZyme® Technology
Effective COVID-19 management is dependent on reliable and frequent testing. Disruptions in global manufacturing supply chains continue to limit availability of laboratory diagnostic kits, impacting local testing strategies.
SpeeDx utilises PlexZyme® technology, de-coupling the detection probe from the primer sequence to produce universal probes which can be used across our entire product portfolio. Our production can stockpile probes well in excess of ‘market demand’ to negate supply chain constraints. This enables us to readily ship kits in high volumes at all times – ensuring no interruptions to your daily laboratory testing. Learn more.